Clinical Trial Update: E-cigarettes as a Harm Reduction Strategy [NA]

View source ↗

Summary

A trial sponsored by Prisma Health-Upstate evaluated whether e-cigarettes could serve as a harm-reduction strategy for smokers; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tobacco Use Disorder

Snippet

Sponsor: Prisma Health-Upstate | Conditions: Smoking | NA | Status: COMPLETED